Viewing Study NCT00378833


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2025-12-26 @ 1:28 AM
Study NCT ID: NCT00378833
Status: COMPLETED
Last Update Posted: 2017-02-16
First Post: 2006-09-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module